glp-1 compounders Out of Shortage, Into Controversy: The Fight Over Compounding 🚨 FDA Moves to Permanently

Adverse effects of testosterone replacement therapy: An update on the evidence and controversy

December 3 Product: Biocon Biologics Yesintek Indication: Crohns disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis The FDA on Monday signed off on Biocon Biologics Yesintek (ustekinumab-kfce), a biosimilar to Johnson & Johnsons blockbuster antibody Stelara

GRAS food ingredient note AOD-9604 was self-affirmed as Generally Recognized As Safe (GRAS) by an industry expert panel for limited food-ingredient use based on the Phase 1 and Phase 2 safety data

Advice to action now: Train your staff on the impact of these medications and encourage them to follow the news in relation to it Start building your own GLP-1 protocol and have programs specifically geared towards muscle retention and fat loss When a new member signs up, ask if they are on GLP-1 medication as part of the onboarding process Put a note in the contract saying if they start a GLP-1 medication, they need to notify you Become an educator - people taking the medication may not realize they need to resistance train to keep muscle, produce content that is educational in nature on this